We are live on
!
Find out more
MA
Madrone Advisors Portfolio holdings
AUM
$1.39B
1-Year Est. Return
10.34%
This Fund
S&P 500
This Quarter
Est. Return
-17.64%
1 Year Est. Return
-10.34%
3 Year Est. Return
-10.39%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.62B
AUM Growth
-$415M
(-20%)
Cap. Flow
-$55.4M
Cap. Flow
% of AUM
-3.43%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
1
Reduced
1
Closed
1
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total World Stock ETF
VT
|
+$35.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
QXO
QXO Inc
QXO
|
+$84.8M |
| 2 |
Pacific Biosciences
PACB
|
+$6.37M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Communication Services | 63.41% |
| 2 | Technology | 24.42% |
| 3 | Industrials | 6.1% |
| 4 | Healthcare | 0% |
Similar funds
PL
SRAIM
TIA
1SP
IC
FFBTD
SP
AC
Madrone Advisors's Q4 2025 Portfolio in Review
As of Q4 2025, Madrone Advisors held 6 positions worth $1.62B, down 20% from $2.03B the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Madrone Advisors withdrew a net $55.4M in Q4 2025, closing 1 position and reducing 1 holding. Its most notable exit was Pacific Biosciences, an estimated $6.37M position sold in full.
By sector, the portfolio is most concentrated in Communication Services at 63% of assets, up from 63% a quarter earlier, followed by Technology and Industrials.
Against the trend, Madrone Advisors added an estimated $35.8M to Vanguard Total World Stock ETF.
- Madrone Advisors added most to Vanguard Total World Stock ETF in Q4 2025, an estimated $35.8M increase.
- Madrone Advisors's biggest Q4 2025 reduction was QXO Inc, cutting an estimated $84.8M.
- Madrone Advisors fully exited Pacific Biosciences in Q4 2025, selling an estimated $6.37M.
- Madrone Advisors's ten largest holdings make up 100% of its $1.62B portfolio in Q4 2025.
- Madrone Advisors opened 0 new positions and closed 1 in Q4 2025.
- Madrone Advisors's portfolio value fell 20% quarter-over-quarter to $1.62B.
Based on Madrone Advisors's 13F filing for Q4 2025, filed 13 Feb 2026.